Scientists target cancer Cells' weakness in new trial

NCT ID NCT06600568

Recruiting now Knowledge-focused Sponsor: Istituto Oncologico Veneto IRCCS Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 23 times

Summary

This study looks for better ways to treat T-cell leukemia and lymphoma, a type of blood cancer. Researchers will test combinations of drugs that attack cancer cells by changing their internal balance of reactive oxygen species (ROS). The goal is to find which drug combinations work best to kill cancer cells from patients whose disease has not responded to standard treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for T-CELL LEUKEMIA/LYMPHOMA, ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Istituto Nazionale Tumori Fondazione G.Pascale
RECRUITING

Naples, 80100, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••
Istituto Oncologico Veneto
RECRUITING

Padova, 35128, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

T-CELL LEUKEMIA/LYMPHOMA, ADULT T-CELL LEUKEMIA/LYMPHOMA, ADULT